![]() |
市場調查報告書
商品編碼
2149612
2034年培養肉配料市場預測-按原料類型、細胞類型、生產階段、肉類類型、最終用戶和地區分類的全球分析Cultivated Meat Ingredients Market Forecasts to 2034 - Global Analysis By Ingredient Type, Cell Type, Production Stage, Meat Type, End User, and Geography |
||||||
全球培養肉原料市場預計到 2026 年將達到 3 億美元,並在預測期內以 37.5% 的複合年成長率成長,到 2034 年將達到 38 億美元。
培養肉成分是指用於利用動物細胞培養生產人造肉的專用營養物質、生長因子、培養基成分、支架材料和其他投入物。這些原料為培養肉生產過程中細胞的生長、增殖、分化和組織發育提供了必要的細胞環境。成分包括胺基酸、蛋白質、維生素、礦物質、脂質、促進生長化合物和專用生物材料。製造商和培養肉研發人員利用這些原料來提高細胞生產力、產品品質、可擴展性和一致性。研究日益關注如何提高原料利用效率並降低生產成本。細胞培養、重組蛋白生產、培養基最佳化和支架技術的進步正在拓展原料的選擇範圍。監管發展、生產經濟性和可擴展性仍然是影響商業化的關鍵因素。
市場動態
對永續肉類生產的需求日益成長
消費者和生產者對永續肉類生產(可減少環境影響)的需求日益成長,推動了培養肉成分的普及。與傳統肉類生產相比,培養肉具有顯著的環境優勢,包括減少土地、水資源和溫室氣體排放。人們對與傳統肉類生產相關的環境和倫理問題的認知不斷提高,也促進了市場擴張。全球肉類需求的成長和傳統生產能力的不足,使得人們對替代肉類來源的興趣日益濃厚。企業對永續性的承諾也加速了對培養肉技術的投資。
生產成本高且難以擴大規模
培養肉成分(尤其是生長因子和培養基)的高昂生產成本是其商業性化應用的一大障礙。從實驗室規模到商業化生產的規模化生產面臨許多挑戰,影響生產的經濟效益和進度安排。有限的產能限制了產品開發和商業性應用的供應。培養肉的法規核准流程因地區而異,且耗時較長。消費者對培養肉的接受度可能取決於其新穎性以及對加工方法的認知。
生長因子和培養基的創新
生長因子和培養基的創新為培養肉生產商帶來了巨大的成長機會。非動物性生長因子和低成本培養基的開發將降低生產成本。支架材料的進步將有助於生產質地更佳的結構化肉品。加大對培養肉研發的投入將加速其商業化進程。原料生產商與培養肉生產商之間的合作將拓寬其應用前景。
來自植物來源肉替代品的競爭
來自植物來源肉替代品的競爭可能會限制培養肉在某些細分市場的普及。經濟壓力可能會影響對培養肉技術的投資。影響培養肉核准的監管變化可能會影響市場發展。消費者對培養肉的懷疑態度可能會影響其普及化。培養肉的快速成長將吸引新的進入者,並加劇競爭。
新冠疫情凸顯了傳統肉類供應鏈的脆弱性,並加速了人們對培養肉作為更具韌性的生產方式的興趣。消費者對食品安全和永續性的日益關注正在推動市場擴張。疫情後時期,對培養肉研發的投資增加。食品體系的轉型持續推動創新。消費者對替代蛋白的認知也不斷提高。
在預測期內,成長因素細分市場預計將佔據最大的市場佔有率。
預計在預測期內,生長因子細分市場將佔據最大的市場佔有率。這是因為生長因子是培養肉生產中最重要且成本最高的成分。生長因子調節細胞增殖和分化,直接影響生產效率和成本。對非動物性生長因子的需求不斷成長,正在推動創新和市場擴張。重組蛋白生產技術的進步正在降低生長因子的成本。生長因子在所有培養肉生產過程中都至關重要。
在預測期內,細胞培養領域預計將呈現最高的複合年成長率。
在預測期內,細胞培養領域預計將呈現最高的成長率,這主要得益於細胞培養技術在培養肉生產中日益廣泛的應用。細胞培養技術使得無需屠宰動物即可生產人造肉成為可能。對細胞培養技術的投資不斷增加,正在加速其商業化進程。消費者對培養肉的接受度持續提高。技術進步正在提升生產效率並降低成本。細胞培養是所有培養肉生產的基礎。
在預測期內,北美預計將佔據最大的市場佔有率,這主要得益於該地區強大的培養肉企業網路、先進的生物技術基礎設施以及對替代蛋白的早期應用。美國擁有眾多領先的培養肉企業,並具備成熟的研發能力。消費者對永續性意識的不斷提高也推動了市場擴張。對食品技術投資的持續成長進一步鞏固了該地區的市場領先地位。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於不斷成長的肉類需求、對替代蛋白投資的增加以及日益增強的永續性意識。中國、日本和新加坡的培養肉產能正在不斷擴大。人們對食品安全的日益關注和不斷增強的環保意識也在加速市場成長。政府對食品技術創新的支持正在創造有利的投資環境。
According to Stratistics MRC, the Global Cultivated Meat Ingredients Market is accounted for $0.3 billion in 2026 and is expected to reach $3.8 billion by 2034 growing at a CAGR of 37.5% during the forecast period. Cultivated Meat Ingredients comprise specialized nutrients, growth factors, culture media components, scaffolding materials, and other inputs used in the production of meat from cultured animal cells. These ingredients provide the cellular environment required for cell growth, proliferation, differentiation, and tissue development during cultivated meat production. Components may include amino acids, proteins, vitamins, minerals, lipids, growth-supporting compounds, and specialized biomaterials. Manufacturers and cultivated meat developers use these inputs to improve cell productivity, product quality, scalability, and consistency. Research is increasingly focused on improving ingredient efficiency while reducing production costs. Advances in cell culture, recombinant protein production, media optimization, and scaffold technologies are expanding the ingredient landscape. Regulatory development, production economics, and scalability remain important factors influencing commercialization.
Market Dynamics
Growing demand for sustainable meat production
Increasing consumer and manufacturer demand for sustainable meat production that reduces environmental impact is driving adoption of cultivated meat ingredients. Cultivated meat offers significant environmental advantages over conventional meat production, including reduced land, water, and greenhouse gas footprints. Growing awareness of the environmental and ethical issues associated with conventional meat production supports market expansion. Rising global meat demand and limited conventional production capacity drive interest in alternative meat sources. Corporate sustainability commitments are accelerating investment in cultivated meat technology.
High production costs and scale-up challenges
High production costs for cultivated meat ingredients, particularly growth factors and culture media, present significant barriers to commercial viability. Scale-up challenges from laboratory to commercial production affect production economics and timelines. Limited production capacity constrains supply availability for product development and commercial applications. Regulatory approval processes for cultivated meat vary across regions and can be lengthy. Consumer acceptance of cultivated meat may be affected by perceptions of novelty and processing.
Innovation in growth factors and culture media
Innovation in growth factors and culture media presents significant growth opportunities for cultivated meat ingredient manufacturers. Development of animal-free growth factors and low-cost culture media reduces production costs. Advances in scaffolding materials enable production of structured meat products with improved texture. Growing investment in cultivated meat research and development accelerates commercialization. Partnerships between ingredient companies and cultivated meat producers expand application possibilities.
Competition from plant-based meat alternatives
Competition from plant-based meat alternatives may limit adoption of cultivated meat in certain market segments. Economic pressures may affect investment in cultivated meat technology. Regulatory changes affecting cultivated meat approval may impact market development. Consumer skepticism regarding cultivated meat may affect adoption. Rapid growth of cultivated meat attracts new entrants and intensifies competition.
The COVID-19 pandemic highlighted vulnerabilities in conventional meat supply chains, accelerating interest in cultivated meat as a resilient production method. Growing consumer focus on food safety and sustainability supports market expansion. The post-pandemic period has witnessed increased investment in cultivated meat research and development. Food system transformation continues driving innovation. Consumer awareness of alternative proteins continues growing.
The growth factors segment is expected to be the largest during the forecast period
The growth factors segment is expected to account for the largest market share during the forecast period as growth factors represent the most critical and expensive components of cultivated meat production. Growth factors regulate cell proliferation and differentiation, directly affecting production efficiency and cost. Growing demand for animal-free growth factors drives innovation and market expansion. Advances in recombinant protein production reduce growth factor costs. Growth factors are essential for all cultivated meat production processes.
The cell culture segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the cell culture segment is predicted to witness the highest growth rate driven by increasing adoption of cell culture for cultivated meat production. Cell culture enables production of meat without animal slaughter. Growing investment in cell culture technology accelerates commercialization. Consumer acceptance of cultivated meat continues growing. Technology advances continue improving production efficiency and reducing costs. Cell culture is the foundation for all cultivated meat production.
During the forecast period, the North America region is expected to hold the largest market share owing to strong presence of cultivated meat companies, advanced biotechnology infrastructure, and early adoption of alternative proteins. The United States hosts major cultivated meat companies with established research and development capabilities. High consumer awareness of sustainability supports market expansion. Growing investment in food technology reinforces regional market leadership.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by growing meat demand, increasing investment in alternative proteins, and rising awareness of sustainability. China, Japan, and Singapore are expanding cultivated meat capabilities. Growing food security concerns and environmental awareness accelerate market growth. Government support for food technology innovation creates favorable investment environment.
Key players in the market
Some of the key players in the Cultivated Meat Ingredients Market include Merck KGaA, Thermo Fisher Scientific Inc., Sartorius AG, Danaher Corporation, Ginkgo Bioworks Holdings, Inc., Roquette Freres, Gelita AG, Cell Guidance Systems, Cultivated Biosciences, Multus Biotechnology Ltd., Mosa Meat, UPSIDE Foods, Believer Meats, Eat Just, Inc., and Wildtype.
In August 2026, Merck KGaA launched a new line of animal-free growth factors specifically designed for cultivated meat production, reducing costs and improving scalability for commercial manufacturers.
In April 2026, Thermo Fisher Scientific Inc. introduced an optimized cell culture media for cultivated meat applications, enabling higher cell densities and improved production efficiency.
In December 2025, Sartorius AG expanded its cultivated meat ingredient portfolio with new scaffolding materials for structured meat production, enabling improved texture and mouthfeel.
In July 2025, Ginkgo Bioworks Holdings, Inc. announced a partnership with a major cultivated meat producer to develop custom cell lines for improved growth and differentiation.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.